STOCK TITAN

IMAX (NYSE) insider Richard Gelfond sells shares totaling multi‑date proceeds

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

IMAX reported Form 144 filings indicating insider dispositions. The filing lists multiple cashless exercises and same-day sales tied to options originally acquired on 06/07/2016, and shows specific open-market sales on 03/10/2026, 04/02/2026, 04/06/2026, 04/10/2026, and 04/13/2026 by Richard Gelfond.

The recorded transactions list share amounts and gross proceeds per trade (e.g., 121,220 shares for $4,860,837.15 on 03/10/2026). This is a routine insider disposition report under Form 144 documenting sales rather than an operational or financial disclosure.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 documents insider sales via cashless exercises and same-day sales.

The record shows a series of reported dispositions by Richard Gelfond with discrete trade dates and gross proceeds, consistent with reporting requirements for Section 16 insiders. The transactions are documented as cashless exercise/same-day sale and open-market sales.

These entries are administrative disclosures; they do not by themselves indicate company-level financial changes. Subsequent filings (Forms 4 or broker records) would provide additional detail on net holdings or any 10b5-1 plan mention.

Securities to be sold (line item) 6,924 shares listed under Securities To Be Sold in the excerpt
Sale on 03/10/2026 121,220 shares gross proceeds $4,860,837.15
Sale on 04/10/2026 135,046 shares gross proceeds $5,106,872.53
Sale on 04/13/2026 97,462 shares gross proceeds $3,620,966.70
Sale on 04/02/2026 12,037 shares gross proceeds $481,520.93
Sale on 04/06/2026 12,987 shares gross proceeds $522,883.89
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
cashless exercise / same-day sale financial
"Compensation -- Cashless exercise / same-day sale"
Compensation -- Stock Options financial
"Acquired as compensation -- Stock Options"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does IMAX's Form 144 filed for Richard Gelfond disclose?

It discloses multiple insider sales reported on Form 144 by Richard Gelfond. The filing lists specific sale dates, share counts, and gross proceeds for each transaction, documenting compliance with rules for securities dispositions by insiders.

How many shares did Richard Gelfond sell on 03/10/2026 according to the filing?

The filing lists a sale of 121,220 shares on 03/10/2026. The same line shows gross proceeds of $4,860,837.15, as recorded in the Form 144 excerpt provided.

Are the transactions described as option exercises or open-market sales?

The excerpt records both: securities were noted as acquired via "Compensation -- Stock Options" and executed as "cashless exercise / same-day sale," and several entries list open-market sales with dates, share counts, and proceeds.

Do these Form 144 entries state whether IMAX receives proceeds from the sales?

The entries list gross proceeds per sale attributed to the reporting person. There is no statement in the excerpt that the issuer receives proceeds; the document records insider dispositions rather than proceeds to IMAX.

Does the filing indicate any trading plan (e.g., Rule 10b5-1) for these sales?

The provided excerpt does not include any language referencing a Rule 10b5-1 trading plan. The lines show exercise and same-day sale mechanics and open-market sale dates, without an explicit statement about pre-arranged plans.